Which of the following is the classification proposed by the International Lymphoma Study Group for non-Hodgkin’s lymphoma?
The main classifications I remember are the Rappaport classification, which was an older system, the Working Formulation (WF), which was a later system, and the WHO classification, which is the current standard. Wait, the International Lymphoma Study Group... Hmm, maybe they're referring to the Revised European-American Lymphoma (REAL) classification? Because the REAL classification was developed by a collaboration including the International Lymphoma Study Group. Then the WHO classification actually adopted the REAL system and expanded it. So the REAL classification is the one proposed by that group.
Now, the options A, B, C, D aren't given, but the correct answer is supposed to be the REAL classification. Let me check the options. If the options include Rappaport, Working Formulation, REAL, and WHO, then the answer would be REAL. The key here is to remember that the REAL classification was a collaborative effort and later became part of the WHO system. The user probably has options where REAL is one of the choices. The Rappaport is outdated, Working Formulation is a later system but not the one by the International Lymphoma Study Group. The WHO classification is the updated version based on REAL. So the correct answer is REAL. Now, I need to structure the explanation accordingly, making sure to explain why the other options are incorrect and provide the clinical pearl about the transition from REAL to WHO.
**Core Concept**
The International Lymphoma Study Group’s classification system for non-Hodgkin’s lymphoma (NHL) is the **Revised European-American Lymphoma (REAL) classification**, which replaced earlier systems like the Rappaport and Working Formulation. It integrates morphological, immunophenotypic, and clinical features to categorize NHL subtypes.
**Why the Correct Answer is Right**
The REAL classification, proposed in 1994, was developed through collaboration between European and American lymphoma experts. It introduced a more biologically and clinically relevant framework by classifying NHL into categories like diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma. This system emphasized the importance of immunohistochemistry and genetic markers (e.g., BCL-2 in follicular lymphoma), laying the foundation for the current WHO classification.
**Why Each Wrong Option is Incorrect**
**Option A:** *Rappaport classification* is outdated, focusing solely on morphology and dividing lymphomas into lymphocytic, histiocytic, or mixed types. **Option B:** *Working Formulation* (1982) improved upon Rappaport but lacked molecular data and grouped aggressive vs. indolent lymphomas poorly. **Option C:** *WHO classification* (2001) is the current standard but evolved from the REAL system, not the original classification by the International Lymphoma Study Group.
**Clinical Pearl / High-Yield Fact**
Memorize: **REAL → WHO**. The REAL classification was a pivotal step in lymphoma taxonomy, emphasizing molecular insights (e.g., BCL-2, BCL-6, MYC translocations) and